Meeting program

“Sharing radically novel visions in Cancer“

June 02-03, 2017

Haus Zwingli



Friday, June 2, 2017


Session I:

09.15 – 09.30h                       Welcome/ Introduction

09.30 – 10.00h                       Klas Wiman: Can we cure cancer by targeting mutant p53?

10.00 – 10.30h                  Martin Eilers: Targeting Myc Function and Stability: Strategies and Expectations.

10.30 – 10.45h                       Juha Klefström: Reactivating Myc Apoptosis Pathway in Breast Cancer. (Abstract talk)


10.45 – 11.15h                       Coffee break


Session II:

11.15 – 11.45h                       Andrea Califano: Systematic elucidation and pharmacological targeting of tumor checkpoints: a new take on precision cancer medicine.

11.45 – 12.15h                       Carlos Caldas: Addressing the model bottleneck in breast cancer by developing humanised explants.

12.15 – 12.30h                       Angela Relogio: Ink4a/Arf: a switch-like mechanism for the regulation of the circadian clock via RAS. (Abstract talk)

12.30 – 14.15h                       Lunch/ Postersession


Session III:

14.15 – 14.45h                       Karin Rodland: Modeling Drug Response in Cancer: Are we measuring the  right systems? 

14.45 – 15.15h                       Luca Grumolato: New models of drug resistance in a context of intratumor heterogeneity.

15.15 – 15.30h                       Jean Hausser: Evolutionary trade-offs in tumor development. (Abstract talk)

15.30 – 16.00h                       Lou Staudt: Rational combination therapy to overcome oncogenic survival pathways and therapeutic resistance.


16.00 – 16.30h                       Coffee break


Session IV:

16.30 – 17.00h                       Daniel Peeper: Developing multi-angle anticancer therapies.

17.00 – 17.15h                       Claudia Paret: About the origin of metastases of brain cancer: lesson from the CNS HGNET-BCOR subtype. (Abstract talk)

17.15 – 17.45h                       Benjamin Neel: Finding effective combination therapies for cancer.

17.45 – 18.15h                       Boris Bastian: The molecular pathology of melanoma.

18.30h                                    Dinner Buffet at the conference site

20.00h                                    Speakers’ Dinner



Saturday, June 3, 2017


Session V:

09.00 – 09.30h                       Sheila Stewart: Age-related changes in the tumor microenvironment drive tumorigenesis.

09.30 – 09.45h                       Vijay Kumar Ulaganathan: Harnessing the spatially regulated molecular mechanisms for precision medicine in cancer. (Abstract talk)

09.45 – 10.15h                       Frank Steinicke: Virtual reality in biomedical research.


10.15 – 10.45h                       Coffee break


Session VI: 

10.45 – 11.15h                       Eirini Papapetrou: Insights from reprogramming human cancer to pluripotency.

11.15 – 11.45h                       Eduardo Moreno: Death by tissue destruction.

11.45 – 12.15h                  Round table discussion: Single cell -omics, multimodal co-targeting, ultra-precision personalized – Is this the future cancer medicine?

                                               Debaters: Lou Staudt, Karin Rodland, Daniel Peeper, Benjamin Neel


12.15 – 13.00h                       Lunch


Session VII:

13.00 – 13.30h                       Tak Mak: Beyond Targeting Oncogenes: Emerging Anti-Cancer Strategies.

13.30 – 14.00h                       Clemens A. Schmitt: Novel therapeutic approaches.

14.00 – 14.15h                       Final remarks



14.15 – 15.15h                       Postersession and coffee